Shopping Cart
Remove All
Your shopping cart is currently empty
PARP/EZH2-IN-2 (compound 12e) functions as a dual inhibitor targeting both PARP1 and EZH2, with IC50 values of 6.89 and 27.34 nM, respectively. This compound exhibits anticancer activity without toxicity to normal cells, achieving synthetic lethality indirectly by increasing PARP1 sensitivity through EZH2 inhibition, and inducing cell death by modulating excessive autophagy.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PARP/EZH2-IN-2 (compound 12e) functions as a dual inhibitor targeting both PARP1 and EZH2, with IC50 values of 6.89 and 27.34 nM, respectively. This compound exhibits anticancer activity without toxicity to normal cells, achieving synthetic lethality indirectly by increasing PARP1 sensitivity through EZH2 inhibition, and inducing cell death by modulating excessive autophagy. |
| Targets&IC50 | EZH2:27.34 ± 1 nM, PARP1:6.89 ± 0.7 nM |
| In vitro | PARP/EZH2-IN-2 (compound 12e) exhibits optimal cytotoxicity with IC50 values of 2.84 μM against MDA-MB-231 cells and 0.91 μM against BT-549 cells, while showing no toxicity to normal breast cell lines. |
| In vivo | PARP/EZH2-IN-2 (compound 12e) demonstrates superior antitumor activity compared to Niraparib combined with GSK126 when administered via intraperitoneal injection at doses of 20-50 mg/kg. |
| Formula | C33H31N7O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.